Document:

EX-4.1

 Exhibit 4.1 

AMENDMENT NO. 1 TO WARRANT AGREEMENT 

This Amendment (this “Amendment”) is made as of November 18, 2022, by and between Genius Sports Limited,
incorporated under the laws of Guernsey as a non-cellular company limited by shares (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as
warrant agent (the “Warrant Agent”), and constitutes an amendment to that certain Warrant Agreement, dated as of August 13, 2020 (as amended, the “Existing Warrant Agreement”), between dMY
Technology Group, Inc. II (“dMY”) and the Warrant Agent, which was assumed by the Company pursuant to that certain Warrant Assumption Agreement dated as of April 20, 2021, by and among dMY, the Company, and the Warrant
Agent. Capitalized terms used but not otherwise defined in this Amendment shall have the meanings given to such terms in the Existing Warrant Agreement. 

WHEREAS, Section 9.8(iii) of the Existing Warrant Agreement provides that the Company and the Warrant Agent may amend, subject to certain
conditions provided therein, the Existing Warrant Agreement without the consent of Registered Holders as the parties may deem necessary or desirable and in a manner that the parties deem shall not adversely affect the rights of the Registered
Holders; and 
 WHEREAS, the Company desires to amend the Existing Warrant Agreement to provide Registered Holders with the option to
exercise their warrants on a cashless basis, on the terms and subject to the conditions set forth herein. 
 NOW, THEREFORE, in
consideration of the mutual agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree to amend the Existing
Warrant Agreement as set forth herein. 
 1.    Amendment of Existing Warrant Agreement. The Existing Warrant
Agreement is hereby amended by adding a new Section 3.3.1(f) (the “Amendment”): 
 (f) on a
cashless basis, by directing the Company to issue such number of Ordinary Shares over which Warrants are being exercised by the Registered Holder as is equal (but rounded up to the nearest whole number of Ordinary Shares) to the quotient obtained by
dividing (x) the aggregate Warrant Price by (y) the “Fair Market Value” (as defined in this subsection 3.3.1(f)) to a subsidiary of the Company, which will pay the aggregate Warrant Price in cash to the Company
on the Registered Holder’s behalf. Solely for purposes of this subsection 3.3.1(f)), the “Fair Market Value” shall mean the closing price of the Ordinary Shares on the NYSE on the trading day prior to the date on
which notice of exercise of the Warrant is delivered to the Warrant Agent. Should a Registered Holder elect to exercise their Warrants pursuant to this subsection 3.3.1(f), the Company will issue to the Registered Holder the balance (if any) of the
number of Ordinary Shares over which such Warrants are being exercised by the Registered Holder (after the payment of aggregate Warrant Price by, and the issue of Ordinary Shares to, the subsidiary of the Company pursuant to this subsection
3.3.1(f)). 
 2.     Effectiveness. The Company intends to file with the U.S. Securities and Exchange Commission
a registration statement on Form F-4 to solicit consents (the “Consent Solicitation”) from the Registered Holders to amend the Exercise Period in the Warrant Agreement so that the
Warrants will expire at 5:00 p.m., New York City time on January 18, 2023 (twenty business days following the expiration date of the Consent Solicitation) (the “Warrant Expiration Amendment”). Unless waived by the
Company, this Amendment shall not come into effect until, and is conditioned on, the approval of the Warrant Expiration Amendment by the vote or written consent of holders of at least 50% of the outstanding Warrants. 

3.    Miscellaneous Provisions. 

a)    Severability. This Amendment shall be deemed severable, and the invalidity or unenforceability of any term or
provision hereof shall not affect the validity or enforceability of this Amendment or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be
added as a part of this Amendment a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. 

 b)    Applicable Law. The validity, interpretation, and
performance of this Amendment and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another
jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Amendment shall be brought and enforced in the courts of the State of New York or the United States District Court
for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.

 c)    Counterparts. This Amendment may be executed in any number of counterparts (which may include
counterparts delivered by any standard form of telecommunication) and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. The words
“execution,” “signed,” “signature,” and words of like import in this Amendment or in any other certificate, agreement or document related to this Amendment, if any, shall include images of manually executed signatures
transmitted by facsimile or other electronic format (including, without limitation, “pdf,” “tif” or “jpg”) and other electronic signatures (including, without limitation, DocuSign and AdobeSign). The use of electronic
signatures and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as a
manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures
and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code. 

d)    Effect of Headings. The section headings herein are for convenience only and are not part of this Amendment
and shall not affect the interpretation thereof. 
 e)    Entire Agreement. The Existing Warrant Agreement, as
modified by this Amendment, constitutes the entire understanding of the parties and supersedes all prior agreements, understandings, arrangements, promises and commitments, whether written or oral, express or implied, relating to the subject matter
hereof, and all such prior agreements, understandings, arrangements, promises and commitments are hereby canceled and terminated. 

[Signature Pages Follow] 

  
 2 

 IN WITNESS WHEREOF, each of the parties has caused this Amendment to be duly executed as of
the date first above written. 
  

	
	GENIUS SPORTS LIMITED
	
	 /s/ Nicholas Taylor

Name: Nicholas Taylor

	Title: Chief Financial Officer
	
	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	
	 /s/ Michael Mullings

Name: Michael Mullings

	Title: CCOEX-4.2

 Exhibit 4.2 

GENIUS SPORTS LIMITED 

9th Floor, 10 Bloomsbury Way 

London, WC1A 2SL 
 November 18, 2022 

To the Holders of the Warrants (NYSE: GENI WS): 

This letter is to inform you that Genius Sports Limited (the “Company”) is hereby, in accordance with the terms of the
warrant agreement, dated as of August 13, 2020 (as amended, supplemented or otherwise modified to date, the “Warrant Agreement”), lowering the warrant exercise price of its outstanding warrants (CUSIP number G3934V 117) (the
“Warrants”), from $11.50 to a price (if and only if such lowered price is less than $11.50) equal to 74% of the closing price of an ordinary share on the New York Stock Exchange on the trading day prior to the date of delivery of
the exercise notice related to such Warrant (the “Reduced Exercise Price”), conditioned on the satisfaction or waiver of the Condition (as defined below). The Company is lowering the exercise price pursuant to Section 3.1 of
the Warrant Agreement. The changes made to the Warrant Agreement to reflect the Reduced Exercise Price are set forth in Annex A hereto. 

The Company has also entered into an amendment to the Warrant Agreement with the warrant agent, pursuant to Section 9.8 of the Warrant
Agreement, which will provide all holders the option, but not the obligation, to exercise their warrants on a cashless basis if the Condition is satisfied (the “Cashless Exercise Amendment”). The amendment to the Warrant Agreement
to reflect the Cashless Exercise Amendment is set forth in Annex B hereto. 
 On the date hereof, the Company has also filed with the
U.S. Securities and Exchange Commission a registration statement on Form F-4 to solicit consents (the “Consent Solicitation”) from the holders of the outstanding Warrants to amend the exercise period in the Warrant Agreement so that
the Warrants will expire on January 18, 2023 (twenty business days following the first business day following the Expiration Date (defined below) of the Consent Solicitation) (the “Warrant Expiration Amendment” and obtaining
such requisite consent from the holders of the outstanding warrants is referred to as the “Condition”)). 
 The Consent
Solicitation will be open until 11:59 p.m., Eastern Time, on December 16, 2022, or such later time and date to which we may extend. The date and time at which the Consent Period ends is referred to as the “Expiration Date”).

 The ability to exercise your Warrants at the Reduced Exercise Price and pursuant to the Cashless Exercise Amendment is conditioned on the
satisfaction or waiver of the Condition. If the Warrant Expiration Amendment is approved, you would be able to exercise your Warrants at the Reduced Exercise Price on a cash or cashless basis beginning on the business day following the Expiration
Date and for twenty business days thereafter until January 18, 2023. 
 Prior to the satisfaction of the Condition, any exercise of
the Warrants shall be on the terms set forth in the Warrant Agreement as in effect on the date hereof, without giving effect to the Reduced Exercise Price or the Cashless Exercise Amendment. 

The purpose of the Reduced Exercise Price, Cashless Exercise Amendment and Warrant Expiration Amendment is to attempt to simplify the
Company’s capital structure and reduce the potential dilutive impact of the Warrants, thereby providing the Company with more flexibility for financing its operations in the future. If the Warrant Expiration Amendment is approved and you do not
exercise your Warrants prior to January 18, 2023, the Warrants will expire worthless. 
 Thank you for your time. 

 

	
	Sincerely,
	
	 /s/ Nicholas Taylor

Nicholas Taylor

	Chief Financial Officer
	Genius Sports Limited

 Annex A 

The modifications to Section 3.1 of the Warrant Agreement to reflect the Reduced Exercise Price are indicated below by deleting the stricken text
(indicated in the same manner as the following example: stricken text) and adding the inserted text (indicated in the same manner as the following example: inserted text) as set forth below. 

3.1. Warrant Price. Each whole Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant and
of this Agreement, to purchase from the Company the number of Common Stock stated therein, at the price equal to 74% of the closing price of the Ordinary Shares on the New York Stock Exchange on the trading day prior to the date a Registered
Holder delivers an exercise notice to the Company with respect to the amount of Warrants such Registered Holder wishes to exercise (if and only if such price would be less than $11.50 per share) $11.50 per share , subject to the
adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement shall mean the price per share (including in
cash or by payment of Warrants pursuant to a “cashless exercise,” to the extent permitted hereunder) described in the prior sentence at which shares of Common Stock may be purchased at the time a Warrant is exercised. The Company in its
sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than fifteen Business Days (unless otherwise required by the Commission, any national securities exchange on which the
Warrants are listed or applicable law); provided that the Company shall provide at least five days’ prior written notice of such reduction to Registered Holders of the Warrants; and provided further, that any such reduction shall be identical
among all of the Warrants. 

  
 2 

 Annex B 

The modifications to the Warrant Agreement to reflect the Cashless Exercise Amendment are indicated below. A new Section 3.3.1(f) was added in its
entirety. 
 (f) on a cashless basis, by directing the Company to issue such number of Ordinary Shares over which Warrants
are being exercised by the Registered Holder as is equal (but rounded up to the nearest whole number of Ordinary Shares) to the quotient obtained by dividing (x) the aggregate Warrant Price by (y) the “Fair Market
Value” (as defined in this subsection 3.3.1(f)) to a subsidiary of the Company, which will pay the aggregate Warrant Price in cash to the Company on the Registered Holder’s behalf. Solely for purposes of this subsection
3.3.1(f)), the “Fair Market Value” shall mean the closing price of the Ordinary Shares on the NYSE on the trading day prior to the date on which notice of exercise of the Warrant is delivered to the Warrant Agent. Should a
Registered Holder elect to exercise their Warrants pursuant to this subsection 3.3.1(f), the Company will issue to the Registered Holder the balance (if any) of the number of Ordinary Shares over which such Warrants are being exercised by the
Registered Holder (after the payment of aggregate Warrant Price by, and the issue of Ordinary Shares to, the subsidiary of the Company pursuant to this subsection 3.3.1(f)). 

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]